Preliminary Timetable

Print
Thursday, March 22, 2018
Time
Hall A
09:00-10:30
SESSION 1 | OPENING SESSION
10:30-11:00
Coffee Break
11:00-13:00
SESSION 2 | PLENARY LECTURES - ALZHEIMER’S DISEASE (AD)
13:00-13:45
Lunch Break
13:45-16:15
SESSION 3 | PLENARY LECTURES - GENETICS
16:15-16:35
Coffee Break
16:35-17:35
SESSION 4 | PLENARY LECTURES - CHALLENGES
17:35-18:30
Opening Ceremony
18:30
Welcome Reception

 

Friday, March 23, 2018
Time
Hall A
Hall B
Hall C
HALL D
MULTIPLE SCLEROSIS
HEADACHE
STROKE
DEMENTIA
08:00-08:45
Meet the Experts Session - Polish Stroke Society - in UB 2
Meet the Experts Session - in Hazel
08:45-10:55
SESSION 5 | MULTIPLE SCLEROSIS (MS): PATHOGENESIS AND DIAGNOSIS
SESSION 9 | HEADACHE THERAPY
SESSION 13 | ATRIAL FIBRILLATION (AFIB) AND PATENT FORAMEN OVALE (PFO)
SESSION 17 | RISK FACTORS FOR DEMENTIA
10:55-11:10
Coffee Break
11:10-13:20
SESSION 6 | MULTIPLE SCLEROSIS: DISEASE COURSE MODIFYING DRUGS
SESSION 10 | NON-PHAMACOLOGICAL TREATMENT FOR HEADACHE
SESSION 14 | STROKE - CARTOID STENOSIS AND IMAGING
SESSION 18 | ALZHEIMER'S DISEASE (AD): DIAGNOSIS AND THERAPY
13:20-14:20
Industry Sponsored Symposium (Not for CME)
 
14:20-15:05
Lunch Break
14:20-15:05
Meet the Experts - in Hazel
14:20-15:05
Meet the Experts - in UB 2
15:05-16:55
SESSION 7 | MULTIPLE SCLEROSIS: THERAPY OF AGGRESSIVE DISEASE
SESSION 11 | HEADACHE THERAPY, OLD AND NEW
SESSION 15 | STROKE PREVENTION
SESSION 19 | AD: CONCEPTS
16:55-17:10
Coffee Break
17:10-19:00
SESSION 8 | MULTIPLE SCLEROSIS: TREATMENT ISSUES
SESSION 12 | MIGRAINE CAUSES AND MANIFESTATIONS
SESSION 16 | STROKE - ROLE OF SURGERY
SESSION 20 | DEMENTIA - TREATMENT

 

Saturday, March 24, 2018
Time
Hall A
Hall B
Hall C
HALL D
EPILEPSY
PARKINSON'S DISEASE & MOVEMENT DISORDERS
NEUROIMMUNOLOGY
WILSON'S DISEASE
07:00-08:00
E-Poster Presentations in the Exhibition Area
08:00-09:50
SESSION 21 | EPILEPSY: DIAGNOSIS
SESSION 25 | PARKINSON'S DISEASE (PD): ROLE OF GENETICS
SESSION 29 | NEUROIMMUNOLOGY: MS, LUPUS, AND NMO
SESSION 33 |   WILSON'S DISEASE (WD): HISTORY, PRESENT, AND FUTURE
09:50-10:10
Coffee Break
10:10-12:10
SESSION 22 | EPILEPSY  - THERAPY AND MANAGEMENT
SESSION 26 | PD: UNDERLYING MECHANISMS
SESSION 30 | NEUROMYELITIS OPTICA (NMO)
SESSION 34 |  WD: PATHOGENESIS, EPIDEMIOLOGY, THERAPY
12:10-13:10
Industry Sponsored Symposium (Not for CME)
 
13:10-13:55
Lunch Break
13:10-13:55
Meet the Experts - in UB 2
13:55-15:55
SESSION 23 | EPILEPSY: TREATMENT ISSUES
SESSION 27 | PD: PATHOGENESIS AND MODELS
SESSION 31 |  MS - ISSUES IN THERAPEUTICS
SESSION 35 | WD: TREATMENT
15:55-16:15
Coffee Break
16:15-17:00
 
New Player on the Block
16:15-19:00
SESSION 24 | EPILEPSY: VAGAL NERVE STIMULATION (VNS) CASE STUDIES
SESSION 28 | PD: STAGING AND PROTECTION
SESSION 32 | BIOMARKERS IN MS
 

 

Sunday, March 25, 2018
Time
Hall A
Hall B
Hall C
07:00-08:00
E-Poster Presentations in the Exhibition Area
08:00-08:30
EXCELLENCE IN NEUROLOGY AWARD
 
08:30-10:40
SESSION 36 | PLENARY
SESSION 38 | POLISH HEADACHE SOCIETY  SESSION
SESSION 40 | REHABILITATION
10:40-11:00
Coffee Break
11:00-11:45

Meet The Expert - in UB 2

11:00-13:00
SESSION 37 | NEURODEGENERATIVE DISEASES & STROKE
SESSION 39 | HISTORY OF NEUROLOGY IN POLAND

SESSION 41 | DEMENTIA

13:00-13:15
Poster Awards & Closing Ceremony